Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Oct 13, 2026

REVB — Revelation Biosciences, Inc. Dilution Risk Tracker

Track REVB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track REVB — Get alerts when the score changes →

As of October 13, 2026, Revelation Biosciences, Inc. (REVB) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Revelation Biosciences, Inc. has a market capitalization of $3.09M, 3.98M shares outstanding, 13 institutional holders tracked. Stored dilution-related fields include 8.92M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
27
⚠️ Warrant Exposure
90
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 54%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 224% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion model 60%
• Major convertible overhang: 83% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split model est. 30%
• 50-day avg $1.13 approaching $1 threshold
🔔 Track REVB — Get forecast alerts →

Market Data

Market Cap$3.09M
Shares Outstanding3.98M
Float3.44M
Cash$11.50M
Debt$759.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore65/100DilutionWatch score record
Shares Outstanding3.98MVerified float table or market cache
Public Float3.44MVerified float table or market cache
Market Cap$3.09MMarket data cache
Cash Runway13.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants8.92MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 223.8% shares (2025Q4 vs prior)
13 institutional holders · 1.23M shares
#1 SABBY MANAGEMENT, LLC 605.7K shares
#2 ARMISTICE CAPITAL, LLC 434.3K shares
#3 CITADEL ADVISORS LLC 54.7K shares
+ 10 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest1.6K
Days to Cover1.0
% of Float0.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-06
xbrl XBRL CONVERTIBLE 2024-09-23
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual REVB Dilution Snapshot

Revelation Biosciences, Inc. (REVB) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

REVB's DilutionScore is currently 65/100 (High risk), with 4 score changes tracked over 89 days. The score improved from 54/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202665/100HIGH13 days
Sep 28 – Sep 30, 202654/100HIGH3 days
Aug 22 – Sep 27, 202666/100HIGH37 days
Aug 14 – Aug 21, 202661/100HIGH7 days
Jul 16 – Aug 13, 202666/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track REVB Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment REVB files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking REVB — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for REVB
REVB FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.